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Abstract
The present study aimed to investigate the effect of structure (design and porosity) on the matrix
stiffness and osteogenic activity of stem cells cultured on poly(ester-urethane) (PEU) scaffolds.
Different three-dimensional (3D) forms of scaffoldwere prepared from lysine-based PEU using traditional
salt-leaching and advanced bioplotting techniques. The resulting scaffolds were characterized by differen-
tial scanning calorimetry (DSC), thermogravimetric analysis (TGA), scanning electronmicroscopy (SEM),
mercury porosimetry andmechanical testing. The scaffolds had various pore sizes with different designs,
and all were thermally stable up to 300 °C. In vitro tests, carried out using rat bone marrow stem cells
(BMSCs) for bone tissue engineering, demonstrated better viability and higher cell proliferation on
bioplotted scaffolds compared to salt-leached ones, most probably due to their larger and interconnected
pores and stiffer nature, as shown by higher compressive moduli, which were measured by compression
testing. Similarly, SEM, von Kossa staining and EDX analyses indicated higher amounts of calcium
deposition on bioplotted scaffolds during cell culture. It was concluded that the design with larger
interconnected porosity and stiffness has an effect on the osteogenic activity of the stem cells. Copyright
© 2013 John Wiley & Sons, Ltd.
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1. Introduction
Bone tissue engineering (BTE) is a promising alternative
strategy for healing severe bone defects, utilizing cell-loaded
scaffolds with engineering principles. A proper interaction
between the loaded cells and the porous scaffold is important
for the success of the implantable device. Various synthetic or
natural materials, such as ceramics or polymers, are tested
for their ability to support cell adhesion, proliferation and
differentiation. Generally, natural polymers have better
compatibility but may not have the desired strength, while
the synthetic ones offer some advantages, such as controllable
physical, chemical, surface and degradation properties. They
can be easily designed to form porous three-dimensional
(3D) complex structures with high porosity and a high
surface area, which are essential for anchorage-dependent
cells, such as bone cells, to attach, survive and differentiate
(Rada et al., 2012). The role of a scaffold is to act as a
temporary extracellular matrix (ECM) for the regenerating
cells. Thus, the success of tissue engineering is greatly
determined by the properties of the scaffolds and their
in vitro and in vivo behaviours. Many parameters, such as
shape, chemistry, surface roughness and surface energy, as
well as pore size and mechanical strength, affect the cell
response. Cells can sense and respond to external forces
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exerted by the surrounding ﬂuid (Kasper et al., 2008) or by
the stiffness of the substrate (Discher et al., 2005), and
these forces have roles in cell adhesion, locomotion, growth
and differentiation (Wagoner et al., 2011). Pelham and
Wang (1997) developed polyacrylamide-based matrices
having identical chemistry but different ﬂexibility and
showed that differences in substrate ﬂexibility led to
changes in adhesion structures and motility of epithelial
and ﬁbroblast cells; with a faster migration rate of
ﬁbroblasts and elevated lamellipodial protrusion–retraction
activities in epithelial cells. It is reported in the literature
that motor neurons derived from embryonic mouse spinal
cord prefer soft surfaces to onwhich extend branches rather
than hard surfaces (Flanagan et al., 2002) but, contrarily,
ﬁbroblasts spread well on hard surfaces while having a
round shape on soft materials (Engler et al., 2004).
Polyurethanes (PUs) are a very diverse family of
polymers capable of exhibiting a wide range of properties,
depending on their molecular composition and preparation
conditions. They can be smooth elastomeric membranes or
rigid matrices in the form of sponges, ﬁbres, ﬁlms or tubes
and have therefore found various applications in medical
areas (Hasirci, 1991; Burke and Hasirci, 2004). PUs are
known as haemocompatible materials, but still an intense
research is going on to improve their haemocompatibility
and biocompatibility by changing the chemical composition
or by modifying them using various techniques or with
bioactive molecules (Kutay et al., 1990; Kayirhan et al.,
2001; Ozdemir et al., 2002; Aksoy et al., 2008; Nelson
et al., 2012). In PUs, there are ﬂexible ‘soft segments’, which
are generally long chains of polyols, and rigid ‘hard
segments’, which are the result of the reactions between
isocyanates and chain extenders. These domains create
microphase separation and alter the mechanical, thermal
and other properties of the resultant polymer (Ulubayram
and Hasirci, 1992; Hasirci and Aksoy, 2007). Biodegradable
PUs can be synthesized by using ester-containing groups to
enhance enzymatic and hydrolytic disintegration. For this
purpose, various diols, such as poly(caprolactone) diol
(PCL diol), can be reacted with diisocyanate-containing
amino acid molecules (Marcos-Fernández et al., 2006;
Kiziltay et al., 2012). Polycaprolactone (PCL) has beenwidely
studied and used in the production ofmedical devices. It has a
special place in the production of bone tissue-engineering
scaffolds because of its biocompatibility, ease of processing
and the ability to manipulate mechanical and degradation
properties, either as homopolymers or copolymers (Diba
et al., 2011; Sharaf et al., 2012). Especially, its low melting
temperature and good thermal stability enable PCL scaffolds
to be designed and fabricated using rapid prototyping
techniques without applying high-temperature conditions.
In the present study, a lysine based poly(ester-urethane)
(PEU) was synthesized from PCL diol and lysine diisocyanate
(LDI) and, by using this polymer, scaffolds with different
physical forms were prepared with different designs, porosity
and ﬂexibility, using conventional salt-leaching and advanced
rapid prototyping techniques. The inﬂuence of design,
porosity and matrix stiffness on the properties and osteoblas-
tic activity was examined using rat bone marrow stem cells.
2. Experimental
2.1. Materials
Lysine-based PEU was synthesized from PCL diol (MW=
1250; Sigma-Aldrich, Germany) and lysine diisocyanate
(LDI; diisocyanate of the L-lysine methyl ester, kindly
donated by Kyowa Hakko Kogyo Co. Ltd, Japan) by using
stannous octoate (Sigma-Aldrich) as catalyst. The method
for the synthesis of PEU was described previously (Kiziltay
et al. 2012). The other chemicals were obtained from the
following suppliers: 1,4-dioxane from Scharlau (Spain);
dexamethasone, β-glycerophosphate disodium salt and
L-ascorbic acid from Sigma-Aldrich; bovine serum albumin
(BSA) from Fluka (USA); Dulbecco’s modiﬁed Eagle’s
medium (DMEM, high-glucose) and fetal bovine
serum (FBS) from Hyclone (USA); penicillin–streptomycin
(Pen–Strep) solution from HQClone; trypsin–EDTA
(0.25%), glutaraldehyde, cacodylic acid (sodium salt) and
lipase from Pseudomonas ﬂuorescens (40 U/mg) from Sigma
(USA); ﬁbrinogen from Roche (Germany); AlexaFluor 488
phalloidin and DAPI from Chemicon (USA); nucleocounter
reagents from Chemometec (Denmark); and Alamar blue cell
proliferation assay from Biosource (USA).
2.2. Scaffold fabrication
2.2.1. Scaffold fabrication using rapid prototyping
technique
PEU scaffolds were fabricated layer by layer, using a rapid
prototyping technique (Bioplotter®, Envisiontec GmbH,
Germany). Brieﬂy, bulk polymer was placed in a stainless
steel syringe (needle length 28.1mm, needle inner diam-
eter 0.5mm) and heated to 105 °C. When the polymer
melted, CO2 pressure (5mmHg) was applied to the
syringe through a pressurized cap. Rectangular block
models (20×20mm) were uploaded on the Bioplotter
and the 3D scaffold was plotted up to eight layers through
the extrusion of the polymer as ﬁbres. Each layer had a
thickness of about 0.4mm, yielding a ﬁnal eight-layered
scaffold with a thickness of ~3mm. Scaffolds with two
different architectures were produced by changing the
respective orientation of the deposited ﬁbres, using
CAD/CAM software. The basic architecture (BP-B) was
produced by consecutive deposition of the layers, where
each layer (N) was plotted orthogonally to the layer
below (N-1) and was plotted in the same relative position
as layer N-2 (Figure 1b). The offset architecture (BP-O)
was similar to BP-B, but layer N is plotted with in an offset
distance relative to layer N-2 (Figure 1c). Finally the
scaffolds were cut using a circular punch, 6mm in diame-
ter, and used for further experiments.
2.2.2. Fabrication of scaffolds by salt-leaching
PEU solution (15% w/v in dioxane) was poured into glass
Petri dishes, frozen at –20 °C and lyophilized in a freeze-
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dryer (Labconco Freeze Dry, Model 78680, MO, USA). In
order to obtain a highly porous matrix, sieved salt crystals
(180–300μm) were added into the PEU solution in
dioxane (polymer:salt ratio 1:5 or 1:10 w/w). The
solution–salt mixture was poured into glass Petri dishes
and processed as described above. After drying, the
samples were cut with a puncher (diameter 6mm) and
the salt-containing samples were immersed in distilled
water for 2 days and washed by changing the liquid
several times to remove all salt particles. Prepared salt-
leached sponges were designated SP5 and SP10 for the
sampleswith polymer:salt ratios of 1:5 and 1:10, respectively.
2.3. Thermal characterization
The thermal behaviours of scaffoldswere characterized by dif-
ferential scanning calorimetry (DSC) and thermogravimetric
analysis (TGA). DSC was used to determine the
glass-transition temperature (Tg) and crystalline melting
temperatures (Tm) under a nitrogen atmosphere, using a
DuPont 2000 Differential Scanning Calorimeter at a rate of
10 °C/min in the temperature range –100 °C to 100 °C.
Thermal stability and thermal decomposition investigations
of the polymer were achieved by thermogravimetric analysis,
using a Perkin-Elmer Pyris 1 TGA instrument (USA) under a
nitrogen atmosphere.
2.4. Determination of porosity and pore size
distribution
Scaffold porosity was determined using a liquid displace-
ment method with a pycnometer. The sample and the
empty pycnometer with glass stopper was weighed and
recorded as ms and mp, respectively. The weight of the
pycnometer ﬁlled with decane (non-solvent for the
samples) was recorded as m1. The total weight containing
the sample (pycnometer+decane+ sample) was recorded
as m2. Mass of decane (md) was found by subtracting
(ms +mp) from m2. Volume of pycnometer (V1) was
calculated as follows: Vl = (m1 – mp)/ρd, where ρd is the
density of decane.
Volumeof the sample (Vs)was calculated by taking the vol-
ume differences of decane and the pycnometer. The percent-
age porosity (P) of each scaffoldwas determined according to
the following equation: P(%)= [(Va – Vs)/Va]×100,
where Va is the apparent volume of the cylindrical sample
calculated from its dimensions.
Pore size distributions of the freeze-dried and salt-
leached scaffolds were determined using a Mercury intru-
sion porosimeter (Quartachrome Corp., USA).
The porosity of the bioplotted scaffolds were assessed
by micro-computed tomography (μCT; m-CT 20, Scanco
Medicals, Switzerland). Scanner settings were 40 keV
and 248mA. Entire scaffolds were scanned in around
200 slices.
2.5. Mechanical tests
The compressive mechanical properties of PEU scaffolds
were studied using a Lloyd LRX 5K Mechanical Tester,
controlled by a computer running program (WindapR).
For compression tests, samples in cylindrical shape were
placed between compression presses and compressed at
a speed of 2mm/min. The compressive elastic modulus
was evaluated from the initial linear elastic region of the
stress–strain curves.
2.6. In situ degradation proﬁles of scaffolds
The stability of the various types of scaffolds was
evaluated by incubating in aqueous media, with and
without the presence of Pseudomonas lipase enzyme.
Degradation experiments were carried out according to
the Standard ASTM F-1635. For enzymatic degradation,
each scaffold was placed into a vial containing 5ml PBS
(0.1M, pH7.4) with 0.18 U/ml enzyme and 0.02% sodium
azide to inhibit bacterial growth, and incubated at 37 °C in
a water bath shaker. The solutions were changed every
day. Samples were removed periodically, washed with
distilled water, freeze-dried and weighed in order to
determine the weight loss due to degradation. The weighed
samples were then placed back into fresh PBS medium
containing enzyme. The same steps were followed for
hydrolytic degradation, except that enzyme was not added
into the PBS solution. Three parallel experiments were
carried out for each type of specimen and the measured
values were averaged. Percentage of weight loss was calcu-
lated as follows: weight loss (%)=[(W0 – W1)/W0]×100,
where W0 and W1 are the weight of the dry sample before
and after hydrolytic or enzymatic degradation, respectively.
Figure 1. Plotting of melted PEU: (a) layer-by-layer; (b) BP-B; (c) BP-O (20×20×3mm)
Poly(ester-urethane) scaffolds
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2.7. In vitro studies
2.7.1. Modiﬁcation of PEU scaffolds with oxygen
plasma
All 3D scaffolds were treated with oxygen plasma in order to
enhance the wettability of the samples prior to cell culture
tests. For this purpose, 3D scaffolds were placed in a plasma
chamber (with a SEREN IPS R 300 13.56MHz power
supply; Advanced Plasma Systems, St. Petersburg, USA)
and subjected to oxygen plasma (100W) for 3min. The
samples were then sterilized under UV light for 30min for
each surface and then used in cell culture studies.
2.7.2. Isolation and culture of mesenchymal
osteoprogenitor cells
Bone marrow stem cells (BMSCs) were obtained from the
femoras and tibias of 6week-old, male Sprague–Dawley
rats and cultured as previously described (Yilgor et al.,
2008). All procedures were in full compliance with
Turkish Law 6343/2 (Veterinary Medicine Deontology
Regulation 6.7.26) and with the Helsinki Declaration of
Animal Rights (Bennett, 1994). 100μl cell suspension
containing 5×104 cells were seeded on each sample
and incubated for 30min at 37 °C to allow cell
attachment. Then 1ml osteogenic medium (DMEM
supplemented with 10% FCS, 10mM β-glycerophosphate,
50 μg/ml L-ascorbic acid and 10nM dexamethasone in
the presence of 100 U/ml penicillin and 100μg/ml
streptomycin) was added. The cells on the scaffolds were
then allowed to grow for predetermined periods at 37 °C
in a humidiﬁed atmosphere containing 5% CO2 and the
medium was changed every other day.
2.7.3. Microscopy and image analysis
Themicrostructures of 3D PEU scaffolds were characterized
using scanning electron microscopy (SEM; FEI Quanta
400F, Holland). The samples were mounted on aluminium
stubs and sputter-coated with gold–palladium (AuPd)
under an argon atmosphere. For examination of cell
morphology and deposited minerals, cell-seeded samples
were ﬁxed with 2.5% glutaraldehyde in 0.14M sodium
cacodylate buffer, pH7.4, for 2 h at room temperature,
rinsed in cacodylate buffer and freeze-dried. Themean pore
sizes of all scaffolds were determined using ImageJ
software.
2.7.4. Cell proliferation
The numbers of viable cells in the samples were assessed
using Alamar blue assay (US Biological) at different time
points. Prior to the measurements, the culture medium
in the wells was discarded and the wells washed with
sterile PBS to remove any remaining medium. Alamar
blue solution (10%, 1ml in colourless DMEM) was added
to the wells and incubated at 37 °C and 5% CO2 for 1 h.
Then, 200μl test solution was transferred to a 96-well
plate and absorbance values were determined at 570 nm
and 595 nm, using a plate reader (V max Microplate
Reader, Molecular Devices, USA). The test medium in
the wells was then discarded, washed with sterile PBS,
fresh complete medium was added to the wells and the
incubation was continued.
2.7.5. Determination of matrix mineralization
Mineralization on 3D scaffolds was examined by von
Kossa staining and SEM/EDX analysis after 5weeks of
culture. For von Kossa staining, seeded scaffolds were
ﬁxed with 4% paraformaldehyde for 15min, washed with
distilled water and incubated in 5% AgNO3 under UV
light for 30min. After rinsing with distilled water many
times, the samples were treated with 5% sodium
thiosulphate for 5min in order to remove unreacted silver.
Then the samples were rinsed in distilled water several
times before visualization under light microscopy. For
EDX analysis, samples were prepared in the same way as
described for SEM analysis.
3. Results and discussion
3.1. Thermal properties
The response of a polymer to heat is important, since it
causes variations in the physical properties of the material
at different temperatures. The glass transition tempera-
ture (Tg) of PEU synthesized in this study is below room
temperature, and PEU shows elastomeric behaviour at
body temperature. The thermal properties of the prepared
PEU matrices were determined by DSC and TGA. The
ﬁrst-heating DSC thermograms and TGA curves for
different specimens, namely unprocessed polymer in the
smooth ﬁlm (SF) form, freeze-dried sponge (SP0), salt-
leached sponge (SP10) and bioplotted basic (BP-B)
structured samples, are presented in Figure 2a and b,
respectively. All samples demontrated similar Tg values
(in the range –45 °C to –43 °C), while the melting peaks
(Tm) showed some shifts (about 45 °C, 41 °C, 40 °C and
51 °C for SF, SP0, SP10 and BP-B, respectively), as can
be observed in Figure 2. Except for SP0, the other samples
had multipeaks demonstrating the existence of crystals of
different sizes and/or imperfections. High Tm values were
obtained for bioplotted ones; this was expected, since
these samples get some chain orientation during process-
ing. For BP-B, the peak near 39 °C is probably due to
melting of small and imperfect crystallites formed during
processing of macro-chains, whereas the peak with the
highest melting point of all the studied samples, at 51 °
C, is due to a more perfect orientation of chains forming
the crystal domains.
The low melting point is desirable for melt-processing
techniques; however, Tm at around 45 °C makes the
polymer unsuitable for thermal sterilization. Thus, the
differences in melting thermograms can be attributed to
A. Kiziltay et al.
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different preparation of the mentioned three specimens:
The cast ﬁlms, freeze-dried and salt-leached samples were
prepared in dioxane; bioplotted samples were obtained by
a melting process. Therefore, solvent effect and melting
process affected the orientation of the chains, the
intermolecular forces between them and the crystalliza-
tion with different thermal responses.
TGA thermographs showed the thermal stability of the
polymer up to 250 °C, and above that temperature a
similar weight loss pattern was observed for all samples,
solvent-cast ﬁlms, freeze-dried sponges, salt-leached
sponges or rapid prototyped structures (Figure 2b). The
degradation temperatures were detected around 250 °C,
270 °C, 280 °C and 290 °C for SP0, SP10, SF and BP-B,
respectively. The lowest degradation temperature was
observed for freeze-dried sponges and shifted to higher
values. This can be explained as follows: the presence of
charged salt particles can cause some ionic interactions
with the polar sides of the macro-chains. This interaction
leads to organization of the macro-chains. Similar
organizations and stronger interactions between
polymeric chains could also occur in ﬁlms and bioplotted
scaffolds. These interactions enhance thermal stability
and shift the degradation temperature to higher values
(Figure 2b).
3.2. Morphology of unseeded scaffolds
The morphology and pore interconnections of porous
structures of the 3D scaffolds were examined by SEM
(Figure 3). The bioplotted scaffolds as basic (BP-B) or as
offset (BP-O) conﬁgurations had fully interconnected pore
architectures with a strand diameter, strand distance and
pore size of ~450 μm. SEM images of all scaffolds were
analysed via the ImageJ program to obtain average pore
size values. According to this image analysis, the scaffolds
were found to have an average pore size of 80m, 207,
Figure 2. (a) DSC thermograms of PEU matrices and (b) TGA curves of smooth ﬁlm (SF), freeze-dried (SP0), salt-leached (SP10) and
bioplotted (BP-B) samples
Figure 3. SEM images of PEU scaffolds fabricated by Bioplotter (BP-B and BP-O), freeze-drying (SP0) and salt-leaching (SP5 and SP10)
Poly(ester-urethane) scaffolds
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230, 421 and 488μm for SP0, SP5, SP10, BP-B and BP-O,
respectively, with the pore diameters in the ranges
20–120, 30–300, 30–350, 350–500 and 350–500μm,
respectively (Table 1).
The surface area:volume ratios of the salt-leached (SP5
and SP10) sponges were greatly increased compared to
SP0 sponges obtained by freeze-drying. A higher surface
area:volume ratio provides more space for the cells to
attach, and thus would increase the percentage of total
cells interacting and proliferating in the scaffolds. SEM
images also revealed the presence of numerous pore inter-
connections, with at least 30 μm pores in salt-leached
scaffolds, which were expected to promote vascular and
tissue ingrowth when implanted.
3.3. Porosities, pore size distributions and
mechanical properties of scaffolds
The microstructures of the scaffolds are deﬁned by their
pore size and porosity values. Porosity refers to the overall
percentage of void space within a solid, whereas pore size
indicates the diameter of individual voids in the scaffold
(Kim et al., 2010). It is of general acceptance that porosity,
mean size, pore size distribution and pore interconnectivity
play a critical role in scaffold design and production because
of their importance for cell migration, proliferation and ECM
formation (Hong et al., 2008). Permeability of a scaffold is
also important for nutrition diffusion and waste clearance.
Some researchers reported the pore size as determinant for
sufﬁcient tissue ingrowth, where a minimum pore size for
tissue ingrowth and vascularization was indicated as
100μm (ASTM F2450), while some others suggested that
the controlling factor is the pore interconnection size, which
is related to both pore size and the extent of porosity. A min-
imumpore diameter is important so that as the cells prolifer-
ate, the pore diameter will eventually drop andmight inhibit
the penetration of the cells and lead to a decrease in cell vi-
ability. For bone tissue engineering, the ability of a scaffold
to enhance osteogenic differentiation and support new bone
formation is dependent pretty much on the pore size, poros-
ity and pore interconnectivity of the scaffold. The impor-
tance of scaffold porosity and pore size can be attributed to
the native structure of bone, which itself is a porous tissue.
Cortical bone is mainly a dense structure, but its small po-
rous region (10% of the total) allows vascularization and
cellular inﬁltration. In contrast, cancellous bone has a
highly porous structure (50–90%) (Mistry and Mikos,
2005). In this study, the percentage porosity values of the
bioplotted scaffolds were found to be 65% and 56% for
BP-B and BP-O, respectively. As observed from the SEM im-
ages, the pores were interconnected throughout the whole
structure, with a controlled pore size of ca. 450μm. This
is especially important, as most scaffolds produced by con-
ventional methods do not have interconnectivity and the
pore sizes may have variations in the structure. The per-
centage porosity of the freeze-dried scaffolds was found to
be 33% using the pycnometer. Leaching by salt particles
caused an increase in the porosity of up to 85% and 96%,
depending on the amount of salt particles used. The poros-
ity proﬁles of all 3D scaffolds are shown in Table 1.
Pore size distribution analysis was not applied for
bioplotted scaffolds, since they were produced with homo-
geneous pore sizes. For the samples prepared by freeze-dry-
ing and salt-leaching, pore size distribution plots conﬁrmed
SEM observations. The results showed that pores with sizes
of 5μm are present in all scaffolds, even those prepared
with a high salt content. Figure 4a shows distributions of
Figure 4. (a) Pore size distributions of spongy scaffolds prepared by freeze drying (SP0) and salt-leaching (SP5 and SP10); and (b)
degradation proﬁles of 3D scaffolds in PBS with 0.18 U/ml lipase (n=3)
Table 1. Porosity and compressive modulus values of the 3D scaffolds
Sample* Weight (mg) Mean pore size (μm) Pore size range (μm) Porosity (%) Compressive modulus (E, kPa)
SP0 28±3 80 20–120 33 584±66
SP5 19±4 207 30–300 85 146±6
SP10 12±4 230 30–350 96 38±2
BP-B 36±2 421 350–500 65 4720±540
BP-O 36±2 488 350–500 56 3450±610
*Sample dimensions: d=6mm, h=3mm.
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pore sizes of spongy scaffolds in the range 5–200μm, as
obtained from a mercury porosimeter. It is seen that the
overall macroporosities of SP5 and SP10 were higher than
that of SP0, as expected. In SP5 and SP10, the fraction of
bigger pores increased with the addition of salt particles.
For SP0, the fraction of pores> 50μm is negligible, while
for SP5 and SP10 there is a considerable fraction> 200μm.
Scaffold features such as pore structure, mechanical
strength and degradation properties play important roles
in the growth and function of cells, since speciﬁc cells need
mechanical stimuli generated by the scaffold to mediate
cell stiffening, due to cell focal adhesion attachments
(Hing, 2005). Thus, parameters such as molecular weight,
crystallinity, microstructure (porosity, mean pore size,
pore shape, interconnectivity, speciﬁc surface area, etc.)
and preparation method that inﬂuence scaffold stiffness
would inherently inﬂuence the cell response. Different
cells show varying responses. For example, mesenchymal
stem cells (MSCs), ﬁbroblasts and epithelial cells have
been shown to exhibit better cell spreading, adhesion
and proliferation on stiffer scaffolds (Keogh et al., 2010).
Compressive elastic modulus is a measure of material
stiffness. In this study, spongy scaffolds (SP0, SP5 and
SP10) exhibited similar stress–strain behaviour character-
istic of low-density, elastomeric open-cell foams as
deﬁned by Harley et al. (2007). As seen in Table 1,
bioplotted scaffolds (BP-B and BP-O) displayed signiﬁ-
cantly higher compressive stiffness than the spongy
scaffolds obtained by freeze-dried (SPO) and salt-leached
(SP5 and SP10) samples. Addition of leaching particles
decreased the compressive elastic modulus of SP0 from
584±66 kPa to 146±6 kPa for SP5 and to 38±2 kPa
for SP10 under dry conditions, as expected. In the case
of bioplotted scaffolds, it was observed that alteration of
ﬁbre orientation from basic (BP-B) to offset (BP-O)
architecture led a decrease in compressive modulus from
4720±540 kPa to 3450±610 kPa, due to juxtaposition
of sequential ﬁbres along the z axis. Yilgor et al. (2008,
2010) also showed that scaffolds with basic conﬁguration
exhibited higher mechanical strength. Mechanical proper-
ties can be attributed to differences in micro-architecture
and porosity. SP10 had the highest porosity, with a value
of 96%, and thus showed the lowest mechanical strength,
while bioplotted BP-B and BP-O had the highest elastic
modulus values. This can be explained by reorientation
of PEU chains during melt processing to form strong
molecular interactions and a more crystalline structure,
as conﬁrmed by DSC and degradation studies. Increase
of crystalline amount leads to increase in mechanical
strength.
As a supportive matrix for cell culture, a scaffold must
have appropriate mechanical strength. Generally, the
optimum value for mechanical strength is correlated with
the strength of the target tissue, but a strength of at least
100 kPa is reported to be necessary (Zhang et al., 2006).
Compressive moduli for cancellous bone are given as
50–500MPa, depending on anatomical location (Hench,
1991). When compared to natural bone, it is seen that the
compressive moduli of all prepared scaffolds, including
bioplotted ones, were lower than this reported range. On
the other hand, prepared scaffolds seem to have potential
mechanical stiffness to support osteogenic differentiation.
It has been indicated that scaffold stiffness plays an
important role to induce differentiation into the osteogenic
lineage. It was shown that human MSCs differentiated into
osteogenic phenotypes on two-dimensional (2D) substrates
with elastic modulus> 34 kPa; below this value, MSCs dif-
ferentiated into neural or myogenic phenotypes (Pek et al.,
2010). They further conﬁrmed the effect of matrix stiffness
on the differentiation of human MSCs in 3D scaffolds.
These ﬁndings showed that PEU-based scaffolds are not
useful for load-bearing applications, but can be used for
bone defects which demand only low compressive strength
and for soft tissue applications.
3.4. In situ degradation proﬁles of PU scaffolds
PEU matrices obtained by freeze-drying, salt-leaching and
bioplotting were incubated in PBS in either the presence
or absence of lipase. Lipase is an enzyme present in
human serum, responsible for hydrolysis of ester bonds
in polyesters (Calil et al., 2007). In this study, PEU matri-
ces immersed in PBS with no enzyme addition did not
show any signiﬁcant weight loss up to 30 days (data not
shown). On the other hand, under enzymatic conditions,
different forms of PEU matrices had different weight loss
proﬁles, as shown in Figure 4b.
The order of the remaining weights after 15 days of
enzymatic incubation was found to be: SP10 (46%)< SP5
(65%)< SP0 (86%)<BP-B (91%). Salt-leached scaffolds
with high salt concentrations (SP10) presented the
greatest weight loss among the ﬁve specimens when
immersed in lipase-containing solution. This can be
explained by the presence of larger pore sizes, higher
interconnectivity and higher surface area due to higher
porosity, and therefore higher exposure to enzyme
solution. Controlling the degradation rates of synthetic
polymer scaffolds is one of their advantages over natural
materials. Scaffolds produced from synthetic polymers
such as PCL could preserve their structure without
showing any degradation when incubated in PBS for
years, due to their hydrophobicity (Gan et al., 1999), but
it is also possible to control the biodegradation by
changing the composition and by adding ingredients into
the composition.
3.5. In vitro studies
3.5.1. Surface modiﬁcation of 3D scaffolds
The surface topography and hydrophobicity of scaffolds
play critical roles in regulating initial cell behaviours,
such as cell adhesion and proliferation. Oxygen plasma
treatment is widely used for surface modiﬁcation of
cell carrier materials to make the surface hydrophilic
and to enhance cell adhesion and proliferation (Hasirci
Poly(ester-urethane) scaffolds
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Figure 5. SEM images showing the interaction between the cells and scaffolds of BP-O (a–c) and SP10 (d) representing salt-leached
and bioplotted samples, respectively. Images in the right column are higher magniﬁcations of the corresponding areas indicated on
the left
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et al., 2003). In this part of the study, 3D scaffolds
were treated with oxygen plasma in order to increase
wettability by decreasing the surface contact angle.
After plasma treatment, cell suspension droplets were
immediately absorbed by the scaffolds, while they
continued to stay as droplets on the surfaces of
untreated samples.
3.5.2. Morphology of seeded scaffolds
BMSCs showed good adherent ability on both bioplotted
and salt-leached scaffolds, on which a layer of cells can
be detected (Figure 5). Cells were attached closely with
neighbouring cells and formed a cellular network on
struts as well as within the pores of salt-leached scaffolds.
Cell layers as well as bridging on bioplotted ﬁbres were
observed. The morphology of the seeded scaffolds
indicates good interaction of scaffolds with the cells. SP0
samples were not used for in vitro culture, due to their
relatively small pore size and low porosity.
3.5.3. Cell proliferation on 3D scaffolds
Proliferation ability of BMSCs on scaffolds is shown in
Figure 6. It is known that 3D scaffolds play a vital role in
providing the base for growing cells to adhere and prolif-
erate. In order provide adequate space for cell adhesion,
migration, growth and vascular supply, scaffolds should
have micrometer range pores, high porosity and intercon-
nectivity, which will also maintain proper ﬂuid circulation
in the scaffold (Mandal et al., 2009). For this purpose, an
optimum pore size is needed (pores larger than the size of
cells, preferably> 100–150μm) (Hollis and Flahiff,
1995), as well as adequate size of interconnections to
facilitate cell bioactivities. This is especially important in
bone tissue engineering, where vascularization is limited
(Mitsak et al., 2011). Many studies have pointed to the
importance of permeability for the proliferation of cells.
Mandal et al. (2013) reported better cell proliferation in
scaffolds with a smaller pore size (80–100 μm) but with
higher porosity (96%), compared to those with higher
pore size (200–250μm) but lower porosity (86%).
Freeze-drying and the use of porogen agents is one of
most utilized method to obtain macroporous materials.
However, uncontrolled size and shape of macropores
and interconnections between them, as well as low
mechanical properties, are the main concerns. Similarly,
electrospinning is a preferred method for producing
scaffolds, but low interconnectivity and pore sizes in the
nanommeter range are the primary factors limiting the
extensive use of electrospun scaffolds in tissue engineering.
Joshi et al. (2013) applied a laser cut method to electrospun
scaffolds in order to obtain larger pore sizes (300μm) and
porosity. They indicated that the distances of cellular
inﬁltration were about 350μm and 1000μm across all
layers when rolled scaffolds without and with laser cut,
respectively, were used. Mitsak et al. (2011) reported that
enhanced bone penetration and vascularization was
observed in vivo when scaffold permeability was greater.
By micro-CTevaluation, they showed bone penetration into
high permeability scaffolds, with blood vessel inﬁltration
after 4weeks.
In our studies, it was observed that the number of cells
attached on SP5 and SP10 was almost the same, while it
was relatively lower on bioplotted scaffolds (BP-B and
BP-O) on the ﬁrst day. This was expected, due to the ﬂow
of cell suspension through the very big pores (about
400μm) of these samples. The number of initially
attached cells was signiﬁcantly higher on BP-O scaffolds
than that on BP-B scaffolds, due to a higher available
surface area in the ﬂow path of the cell suspension. If
there is no ﬁbre positioned as offset, there is a direct open
path for cells to escape from the scaffolds. On the other
hand, ﬁbres in an offset position act as a barrier to prevent
cell ﬂow, which further leads to a higher amount of initial
adhesion and proliferation. One point that should be
emphasized is the deformation in the bioplotted scaffold
ﬁbres. The thickness and distances between the ﬁbres of
Figure 6. Proliferation of BMSCs on 3D scaffolds (n=3)
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bioplotted scaffolds are in the range 400–500μm. In some
parts, because of the difﬁculty of ﬂow of the polymeric
material through the syringe, some variations in the
thickness (about –70 μm) occurred. The minimum thick-
ness in the narrowing area was measured as 380μm. If
the cell size (around 10–30 μm) is taken in account, the
variation in ﬁbre thickness is too high for cells to recog-
nize. Therefore, no signiﬁcant effect of these ﬁbres on cell
experiments is expected.
All scaffolds displayed a sharp increase in cell number
after 7 days of culture. The minimum cell number was
observed for BP-B, since the number of cells adhering
initially was much lower than in the other scaffolds.
However, this effect compensated itself in 2weeks
and the cell number became higher than in SP5 and
SP10 scaffolds. This can be attributed the better inter-
connectivity of the pores and much proper mass transfer
of the feeding medium in bioplotted scaffolds (BP-B and
BP-O) compared to the ones prepared by salt-leaching.
As emphasized previously, interconnection of pores is
an important factor to support cell migration, cell
proliferation and mass transfer. Increasing scaffold
porosity will cause increased permeability. Lacroix
and et al. (2013) demonstrated that inadequate porous
structures resulted in limited circulation of the ﬂuid
within the scaffold, which lowered cell viability. Thus,
high porosity and interconnectivity is necessary to
allow an easy circulation of nutrients and growth factors.
In this study, the effects of scaffold porosity on
osteoblastic cell proliferation and activity were investigated
under static conditions. Our results demonstrated that cell
proliferation and cellular activities were enhanced with
increased scaffold permeability. After day 7, the rate of cell
growth decreased because of expression of differentiation
factors (van Griensven et al., 2005). On days 14 and 21,
the number of cells demonstrated parallel relation to the
pore size and interconnectivity.
3.5.4. Mineralization by osteoblastic activity
The ability of cells to produce mineralized matrix and
calcium nodules is an indicator of bone formation
in vitro. In the literature, mineralization is indicated in
different ways, such as ’calciﬁcation’, ’mineral deposi-
tion’, ’calcium salts’, ’mineralized matrix’ and ’bone
nodule formation’. There are several methods used
for the detection of mineralization. These include von
Kossa staining, haemotoxylin staining, EDX analysis,
FTIR and X-ray diffraction, where the von Kossa
staining method has been widely used to examine
mineralization in vitro.
In this study, von Kossa staining for mineralization was
positive for all scaffolds, with the most intense staining in
bioplotted scaffolds (Figure 7A). After staining, calcium
salts are coloured as dark brown or black nodules. Signif-
icant amounts of black-stained deposits were observed
after 35 days of culture on 3D scaffolds, which indicates
that seeded BMSCs differentiated into osteoblasts produc-
ing mineralized tissues. Light microscopy images showed
that small nodules were formed on SP5, while some rela-
tively larger nodules were observed beside small ones on
SP10. von Kossa staining indicated more extensive miner-
alization of osteoblasts on bioplotted scaffolds. Black
deposits covered all the surfaces of ﬁbres on the upper
and lower sides of bioplotted scaffolds, while no apparent
positive staining was observed on unseeded controls.
These results suggest that BMSCs were able to differenti-
ate into the osteogenic lineage in vitro. This suggestion
was further supported by SEM/EDX results. SEM/EDX
analysis was performed in conjunction with von Kossa
staining in order to conﬁrm mineralization. Figure 7B
shows morphological observation of mineral deposition
on salt-leached, spongy and bioplotted scaffolds. At the
end of 5weeks, it was noticeable that all constructs were
covered with multilayers of cells, and cells started ﬁlling
up the pores with extracellular matrix and abundant
mineral deposits, indicating good cell attachment and
proliferation of osteoblasts. SEM images demonstrated
that extracellular mineral deposition was higher on
bioplotted scaffolds than on salt-leached scaffolds, which
was also conﬁrmed by analysing the seeded scaffolds’
surfaces via SEM/EDX imaging, which provides a determi-
nation of the chemical composition of material surfaces.
The amount of elemental calcium (Ca) and phosphorus
(P) was measured from the mineral nodules synthesized
by osteoblasts on the surfaces of different scaffolds, and
the weight percentages of elements measured on days 1
and 35 are shown in Table 2. It is known that calcium
and phosphate serves as the nucleating agent for the
formation of bone hydroxyapatite (HAp). EDX analysis
demonstrates the presence of Ca and P on the surface of
all scaffolds after 5weeks of culture, while these elements
were not detected on day 1, since there was not yet any
mineral deposition. EDX detected low levels of Ca and P
deposition on salt-leached scaffolds compared to bioplotted
scaffolds after 35days of cultivation. Moreover, EDX analy-
sis revealed that the Ca:P ratio of BP-O (~1.60)was close to
the theoretical value of 1.67 attributed to HAp, whereas Ca:
P ratios of SP5 and SP10 (~0.55 for both) were very low
compared to that of HAp. It has been reported that a Ca:P
ratio of< 1.0 is not biomedically important, since the struc-
ture is not stable (Basu et al., 2009). These results indicate
that higher mineralization on bioplotted scaffolds might
result from stiffness of the matrix. It has been stated that
substrate stiffness can inﬂuence the morphology and cell-
speciﬁc protein expression.
3.5.5. Effect of cell proliferation on compressive
properties of 3D PEU scaffolds
The mechanical performances of BMSC-seeded 3D
scaffolds were characterized under wet conditions after
1, 21 and 35 days of cultivation. In natural tissues, the
ECM provides compressive strength to the tissues (Chan
and Leong, 2008). Increase of compressive stiffness of
scaffolds after in vitro cell culture is an indication of
ECM deposition by proliferated cells. The compressive
moduli of seeded scaffolds on days 1, 21 and 35 are
A. Kiziltay et al.
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compared in Table 3. While the compressive modulus of
SP5 increased from 25.6±3.83 to 35.01±2.82 kPa, that
of SP10 changed from 16.38±3.20 to 25.01±4.21 kPa
after 21 days of cell culture. Moreover, the compressive
moduli increased to 44.44±3.48 and 37.40±3.94 kPa
for SP5 and SP10, respectively, with further cultivation
Figure 7. (A) von Kossa staining of mineral deposition on 3D scaffolds after 5weeks of culture; (B) SEM images showing ECM depo-
sition and mineralization on salt-leached and bioplotted scaffolds after 5weeks of culture. Bioplotted: (a–c) top view; (d, e) side view
Poly(ester-urethane) scaffolds
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up to 35 days. Compressive moduli increased by 36% and
73% for SP5 and by 53% and 98% for SP10 after 21 and
35 days of cultivation, respectively. The higher increase
in the mechanical properties of SP10 was most probably
due to its more porous structure compared to SP5, and
this might have resulted in a higher cell penetration and
proliferation of cells throughout the scaffold and thus a
larger amount of ECM deposition after cell culture. This
is in agreement with the literature result reported that
chondrocytes seeded in gelatin scaffolds with higher pore
size showed higher compression strength after cell culture
compared to scaffolds with smaller pore size (Lien et al.,
2010). For bioplotted ones, after 35 days of cultivation,
the compressive moduli of BP-B and BP-O increased from
4610±520 kPa (day 1) to 5095±614 kPa (day 35) and
from 3535±437 kPa (day 1) to 3893±382 kPa (day
35) for BP-B and BP-O, respectively. For both BP-B and
BP-O scaffolds, the increase was approximately 10%. As
seen from these results, the percentage increase in com-
pressive strength after cell culture was more remarkable
in salt-leached scaffolds than in bioplotted ones. This is
because there is a big difference between the initial stiff-
ness of salt-leached scaffolds and bioplotted ones. How-
ever, when total increase was taken into consideration, it
is obvious that the increase in compressive strength was
much higher on bioplotted scaffolds. It is not valid to eval-
uate the efﬁcacy of osseous tissue ingrowth by taking the
initial mechanical property as the only criterion. For ex-
ample, it has been demonstrated that biphasic calcium
phosphate ceramics (BCPs) with low microporosity and
high mechanical strength showed low bioresorption and
bioactivity after implantation, while BCPs with initially
higher microporosity and lower mechanical strength re-
vealed a two- or three-fold increase in mechanical
strength after implantation. The researchers indicated
that highly macroporous BCPs promoted higher ECM de-
position in vivo and better integration with the native tis-
sue (Trécant et al., 1994).
4. Conclusion
In the present study, various macroporous 3D structures
were obtained from lysine-based poly(ester-urethane) by
using bioplotting and salt-leaching techniques, and their me-
chanical and thermal properties and their abilities to pro-
mote osteogenesis of BMSCs were compared. Alamar blue
cell viability tests showed that all scaffolds allowed cellular
attachment, proliferation and osteogenic differentiation.
Due to their higher pore size and interconnectivity, the cell
proliferation rate was higher on bioplotted scaffolds than
on salt-leached ones. Among the salt-leached scaffolds, con-
structs with higher porosity (96%) demonstrated better pro-
liferation compared to constructs with lower porosity (85%).
This can be explained by the presence of larger pores and
higher pore interconnectivity. According to SEM images,
the cells cultured on all 3D scaffolds had good cell prolifera-
tion and efﬁciently mineralized extracellular matrix (ECM).
von Kossa staining results indicated that calcium deposition
was more abundant on bioplotted scaffolds than on salt-
leached constructs. EDX results further supported the von
Kossa staining of mineralization by qualitative and quantita-
tive analysis of calcium and phosphate expression, with the
highest calcium concentration measured on bioplotted scaf-
folds. It was concluded that the substrate stiffness of
bioplotted scaffolds as well as pore size and interconnectivity
enhanced the osteogenic activity. As a result, among the
various PEU scaffolds prepared in this study, bioplotted
BP-O scaffolds in particular possess great potential for non-
load bearing bone tissue engineering applications. Scaffolds
prepared by salt-leaching showed less cell proliferation and
differentiation, since the pores and interconnectivities were
less. However, they can be used as soft tissue scaffolds since
they have the property of biodegradability and the size and
interconnectivity will be better in biological media because
of enzymatic effects.
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Table 2. Weight percentage of elements on different scaffolds seeded with BMSCs
Element SP5 SP10 BP-O
Day 1 Day 35 Day 1 Day 35 Day 1 Day 35
C 71.59 49.54 62.30 49.11 67.86 38.23
O 28.41 39.62 37.47 31.66 31.81 33.64
P 0.00 6.95 0.00 12.36 0.00 10.83
Ca 0.00 3.89 0.23 6.87 0.33 17.31
Table 3. Variations in compressive moduli of seeded 3D
scaffolds by time
Sample E (kPa)
Day 1 Day 21 Day 35
SP5 25.6±3.83 35.01±2.82 44.44±3.48
SP10 16.38±3.20 25.01±4.21 37.40±3.94
BP-B 4610±520 – 5095±614
BP-O 3535±437 – 3893±382
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